Treating insomnia: Current and investigational pharmacological approaches
- 31 December 2006
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 112 (3), 612-629
- https://doi.org/10.1016/j.pharmthera.2005.04.014
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomniaSleep Medicine, 2006
- Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profileLife Sciences, 2005
- Chronic insomnia and performance in a 24‐h constant routine studyJournal of Sleep Research, 2005
- Sleeping with the hypothalamus: emerging therapeutic targets for sleep disordersNature Neuroscience, 2002
- Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakeningHuman Psychopharmacology: Clinical and Experimental, 2001
- A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakeningBritish Journal of Clinical Pharmacology, 1999
- Structure and subunit composition of GABAA receptorsNeurochemistry International, 1999
- GABAA Receptor Subtypes Differentiated by their γ-Subunit Variants: Prevalence, Pharmacology and Subunit ArchitectureNeuropharmacology, 1996
- Expression and pharmacology of human GABAA receptors containing γ3 subunitsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Preliminary Studies on the Absorption, Distribution, Metabolism, and Excretion of THIP in Animal and Man using 14C‐labelled CompoundActa Pharmacologica et Toxicologica, 1981